Environmental impact is another concern, as sevoflurane, like other volatile anesthetics, is a greenhouse gas that has implications for climate change. Anesthesia providers are encouraged to minimize its usage when possible and adopt practices like the use of low-flow anesthesia to reduce environmental footprint.
Moreover, API factories contribute to the overall economy by creating jobs and fostering innovation in chemical processes. They often collaborate with research institutions to develop new synthetic pathways and improve existing production techniques. This collaboration enhances the efficacy of medicines and reduces production costs, ultimately benefiting healthcare systems across the globe.